Revitalizing Cellular Life
REGENEVIA LLC
MENU
REGENEVIA BIO
CONTACT
16192 Coastal Highway
Lewes, DE 19958, USA
REGENEVIA BIO pioneers advanced epigenetic research to drive tissue rejuvenation and longevity.
info@regenevia.bio
Advanced biotech research in epigenetics and tissue rejuvenation
REGENEVIA is a research-driven biotechnology group focused on the study of cellular identity, epigenetic regulation and tissue rejuvenation, with the goal of developing scientifically grounded, patent-protected solutions in the field of biological aging.
Our work is rooted in long-term fundamental research and is oriented toward responsible innovation, technological transfer and future applications in regenerative and anti-aging technologies.
Our Research Background
The scientific foundations of REGENEVIA originate from Long Life Genetics Ltd, a research initiative based in London, active since 2016, dedicated to basic genetic and epigenetic research on cellular aging, biological time and regeneration mechanisms.
Over the years, this research activity has progressively evolved from theoretical and experimental investigation toward structured technological development and intellectual property protection.
REGENEVIA BIO @ All Rights Reserved
Advanced biotech research in epigenetics and tissue rejuvenation.
REGENEVIA LLC 16192 Coastal Highway
Lewes, DE 19958, USA
mail: info@regenevia.bio
The Italian Research Group
The current Italian research group coordinates the definition of research protocols, the scientific architecture of the projects, and the early commercialization strategy of selected patent-protected technologies, particularly in the field of partial and tissue-level rejuvenation.
The core research team includes:
Dr. Giorgio S. C. Linchi
Dr. Marco Felli
Dr.ssa Elvira Di Nucci
Dr.ssa Katia Memoli
The Italian group is actively engaged in the development and initial market positioning of regenerative and anti-aging technologies, with a primary focus on cutaneous, cellular and partial rejuvenation pathways.
International Collaboration
REGENEVIA is currently in the research and negotiation phase for an international partnership, preferably with a research group based in India, aimed at collaboratively addressing the final experimental and validation phases, preceding full patent realization and structured development.
This international cooperation is intended to integrate complementary expertise, advanced laboratory capabilities and scalable research environments, while maintaining scientific rigor and regulatory awareness.
Vision
REGENEVIA operates at the intersection of biology, information and time, pursuing a long-term vision in which aging is understood as a modifiable biological process, approached with caution, scientific responsibility and respect for ethical boundaries.
Our mission is not to promise outcomes, but to build solid scientific foundations for future generations of regenerative technologies.
Important Notice
REGENEVIA conducts research and technology development activities.
The information presented on this website is intended for scientific and informational purposes only and does not constitute medical advice, clinical treatment or therapeutic claims.
The Next Phase
At this stage, REGENEVIA is moving from conceptual and foundational research toward a carefully controlled advanced experimental phase.
This transition requires not only scientific continuity, but also shared vision, complementary expertise and long-term commitment. For this reason, we are actively exploring strategic research partnerships with institutions and groups capable of contributing to the final stages of experimental validation and structured development.
We are particularly interested in collaborations with research groups based in India, where scientific excellence, technical competence and scalable research environments converge in a unique way.
An Open Invitation to Collaboration
REGENEVIA does not seek simple service providers, nor purely financial participation.
We are interested in true scientific and strategic partners willing to engage in:
advanced experimental research aligned with an existing theoretical and patent framework
joint development of late-stage validation protocols
long-term cooperation preceding and accompanying full patent realization
shared responsibility in shaping future regenerative technologies
This is an open yet selective phase, designed to bring together groups that recognize the importance of rigor, patience and depth in a field often distorted by premature claims.
Why This Matters Now
Biological rejuvenation is no longer a speculative idea, but it is also not a finished technology.
We believe the present moment is critical: early enough to shape direction, mature enough to demand seriousness.
Those who join at this stage do not enter a finished structure —
they help define its final architecture.
A Shared Horizon
Our approach is guided by a simple principle:
lasting innovation emerges where deep science meets responsible collaboration.
If you represent a research group, laboratory or institution interested in participating in this next phase, we welcome a dialogue grounded in clarity, competence and mutual respect.